- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03499535
Impact of Smoking Information on Concerns About Radon
17 april 2019 uppdaterad av: Paul Windschitl
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk.
This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals.
Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers.
The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded.
Two studies were conducted.
Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).
Studieöversikt
Status
Avslutad
Detaljerad beskrivning
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk.
This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals.
Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers.
The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded.
Two studies were conducted.
Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).
Participants in both studies were recruited through Amazon's Mechanical Turk (MTurk).
Participants viewed radon messages that varied in the information they communicated about smoking's effect on lung cancer.
In Study 1, smoking information was included or excluded from messages assembled from existing radon pamphlets.
In Study 2, versions of a new radon message either excluded smoking information, described smoking as a major cause of lung cancer, or also described smoking's synergistic effect with radon on lung cancer risk.
After viewing a radon health message, participants completed a variety of measures.
Primary measures assessed respondents' anticipated sense of concern and related reactions if they learned that they/their home had been exposed to elevated levels of radon.
Other key measures included questions about participants' interest and intention to test their home for radon.
Studietyp
Interventionell
Inskrivning (Faktisk)
1390
Fas
- Inte tillämpbar
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Live within the US
- Have an Amazon Mechanical Turk account (website where online study was posted)
Exclusion Criteria:
- None
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Study 1: Radon&Smoking Synergistic/EPA
Participants viewed radon and smoking risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
|
|
Aktiv komparator: Study 1: Radon&Smoking Synergistic/Idaho
Participants viewed radon and smoking risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
|
|
Experimentell: Study 1: Radon Only / EPA
Participants viewed only radon risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
|
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Experimentell: Study 1: Radon Only / Idaho
Participants viewed only radon risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
|
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Experimentell: Study 2: Radon Only
Participants viewed a radon-only message that focused only on the effect of radon on lung-cancer risk.
|
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Övrig: Study 2: Radon and Smoking Isolated
Participants viewed a radon-and-smoking-isolated message that covered the individual effects of radon and of smoking on lung cancer, but without mentioning their synergistic effect.
|
Participants viewed health information detailing the risks of developing lung cancer from radon exposure and smoking.
No information describing the synergistic effects of smoking and radon exposure on lung cancer risk are included.
|
|
Aktiv komparator: Study 2: Radon & Smoking Synergistic
Participants viewed a radon-and-smoking-synergistic message that covered the individual effects of radon and of smoking but that also included information about their synergistic effect.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Conditional Concern Composite
Tidsram: Immediately post-intervention (approx. 1 minute)
|
Composite formed from 4 conditional questions assessing concern, perceived impact on risk and comparative risk, and threat--if exposed to radon
|
Immediately post-intervention (approx. 1 minute)
|
|
Interest in Testing Composite
Tidsram: Immediately post-intervention (approx. 2 minutes)
|
Composite formed from 2 questions assessing importance and intention to test home for radon
|
Immediately post-intervention (approx. 2 minutes)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Worry Elicited by Health Message
Tidsram: Immediately post-intervention (approx. 2 minutes)
|
Single question assessing worry elicited by the health communication material
|
Immediately post-intervention (approx. 2 minutes)
|
|
Likelihood Judgments about Lung Cancer
Tidsram: Immediately post-intervention (approx. 4 minutes)
|
Three items assessing perceived likelihood of developing lung cancer
|
Immediately post-intervention (approx. 4 minutes)
|
|
Elect to Leave Email for Raffle
Tidsram: Immediately post-intervention (approx. 4 minutes)
|
Participants given option to leave email address in case they won one of the 20 radon kits being raffled (Study 2).
|
Immediately post-intervention (approx. 4 minutes)
|
|
Elect to Read More
Tidsram: Immediately post-intervention (approx. 4 minutes)
|
Participants given option to be presented with more information at the end of the session about testing for radon (Study 2).
|
Immediately post-intervention (approx. 4 minutes)
|
|
Concern about Loved Ones If Exposed to Radon
Tidsram: Immediately post-intervention (approx. 4 minutes)
|
Rated how concerned they would be about loved ones if they learned their home had high radon (Study 2)
|
Immediately post-intervention (approx. 4 minutes)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
7 augusti 2015
Primärt slutförande (Faktisk)
22 april 2016
Avslutad studie (Faktisk)
22 april 2016
Studieregistreringsdatum
Först inskickad
30 mars 2018
Först inskickad som uppfyllde QC-kriterierna
13 april 2018
Första postat (Faktisk)
17 april 2018
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
19 april 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
17 april 2019
Senast verifierad
1 april 2019
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 201507727
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
JA
IPD-planbeskrivning
De-identified data and guide will be made available to other investigators upon request.
Tidsram för IPD-delning
Requested data will be made available upon publication of the project.
Kriterier för IPD Sharing Access
Please contact corresponding author Dr. Paul Windschitl at paul-windschitl@uiowa.edu
IPD-delning som stöder informationstyp
- ANALYTIC_CODE
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Radon & Smoking Synergistic
-
Forschungsinstitut für Balneologie und Kurortwissenschaft...In-patient rehabilition hospital Klinik Bad Brambach; University hospital...AvslutadReumatoid artritTyskland
-
Temple UniversityOkändStillasittande livsstil | CigarettrökningFörenta staterna
-
Duke Kunshan UniversityAvslutadRökavvänjning | Livsstil, hälsosamKina
-
University of California, San FranciscoAvslutad
-
National Cancer Institute (NCI)AvslutadSarkom | ÄggstockscancerFörenta staterna
-
University of ChicagoNational Cancer Institute (NCI)AvslutadLever cancer | Gallblåscancer | Extrahepatisk gallvägscancerFörenta staterna
-
Hackensack Meridian HealthNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Indiana... och andra samarbetspartnersAvslutadRökning | Lungcancer | Rökning, tobak | Rökning, cigarettFörenta staterna
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)AvslutadRökavvänjning | Störning av tobaksbrukFörenta staterna
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Avslutad
-
VA Office of Research and DevelopmentAvslutad